When Osmotica spun out of its sister company (Laboratorios Phoenix) in 2000, it retained its original private investor base and subsequently added key employees and Board Members to the shareholder base. Osmotica's primary shareholders hold investments which span numerous pharmaceutical and unrelated industries.